Previous 10 | Next 10 |
home / stock / medif / medif news
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects. New CBN products include CBN:CBD 1:2 Relax Formula Oil and a Northbound high CBN and high CBD vape cartridge. BARRIE, O...
MediPharm is one of very few companies to focus on pharmaceutical cannabis. 2021 is a crucial year for MediPharm investors and the company. Year-to-date results show enough progress for existing shareholders continue holding but new share purchases are not yet warranted. For...
MediPharm Labs Corp. (MEDIF) Q3 2021 Earnings Conference Call November 15, 2021 08:30 ET Company Participants Keith Strachan - President Bryan Howcroft - Chief Executive Officer Greg Hunter - Chief Financial Officer Conference Call Participants Tamy Chen - BMO Capital Markets Shaan Mir - Cana...
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) announced its financial results for the quarter ending September 30, 2021 and said it has a new CEO as the company focuses on international business. Bryan Howcroft is the new CEO for MediPharm who plans to drive international an...
BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids today announced its financial results for the three a...
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release third quarter...
C-Suite healthcare leader, Bryan Howcroft, to lead MediPharm’s next phase of international growth as CEO. Bryan will apply his experience in registering, distributing, and selling medically registered products in the United States, European Union and other global markets. ...
New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity Group Vayamed is a well-established operating medical cannabis company in Germany, where the medical cannabis market is expected to be worth €7.7 b...
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations PR Newswire NEW YORK , Sept. 13, 2021 /PR...
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-control...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...